Insights

We’re acknowledged for our strong market insight and technical know-how

Life sciences
Insights

Penningtons Manches Cooper advises Imperial University spin-out SPARTA Biodiscovery on fundraise and industry partnership

1 November 2023
Read more
News

Penningtons Manches Cooper advises world-leading medical technology company OrganOx on £25 million fundraise

4 August 2023
Read more
Insights

The state of AI regulation in the UK and EU

3 August 2023
Read more
Insights

EU Commission adopts adequacy decision on data transfers under the EU-US Data Privacy Framework

17 July 2023
Read more
Insights

Uncovering the risks of ChatGPT: a litigator’s perspective

18 May 2023
Read more
Insights

The National Security and Investment Act – further guidance on notifications

18 May 2023
Read more
Insights

Is student-created IP fair game?

26 April 2023
Read more
Insights

EMA seeks feedback on draft guidance for when biologics qualify as new active substances

14 April 2023
Read more
Insights

The ‘net zero’ supplier roadmap: new requirements for NHS contractors

4 April 2023
Read more
Insights

The National Security and Investment Act – a year on

2 February 2023
Read more
Insights

Penningtons Manches Cooper acts for SkinBioTherapeutics plc on placing and REX retail offer on AIM

5 January 2023
Read more
Insights

The Moderna v Pfizer-Biontech COVID-19 vaccine dispute: a brief explanation

30 November 2022
Read more
Back to Life sciences